Bionano Genomics (BNGO) Other Non Operating Income (2018 - 2026)

Bionano Genomics has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$619000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$619000.0, down 112.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.7 million (down 55.65% YoY), and the FY2024 annual result was -$10.1 million, up 50.71% from the prior year.
• Other Non Operating Income came in at -$619000.0 for Q1 2026 at Bionano Genomics, up from -$5.5 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $5.1 million in Q1 2025 to a low of -$20.2 million in Q4 2023.
• The 5-year median for Other Non Operating Income is -$156000.0 (2022), against an average of -$1.8 million.
• Across the five-year window, Other Non Operating Income plunged 50307.5% in 2023 and jumped 473.25% in 2025, its largest moves.
• Bionano Genomics' Other Non Operating Income stood at -$40000.0 in 2022, then slumped by 50307.5% to -$20.2 million in 2023, then surged by 58.3% to -$8.4 million in 2024, then surged by 34.13% to -$5.5 million in 2025, then jumped by 88.82% to -$619000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$619000.0 (Q1 2026), -$5.5 million (Q4 2025), and -$219000.0 (Q3 2025), per Business Quant data.